A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is a prevalent urinary malignancy. Despite the recent development of better diagnostic tools and therapy, the five-year survival rate for individuals with advanced and metastatic ccRCC remains dismal. Unfortunately, ccRCC is less susceptible to radiation and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qinyu, Xiao, Xueyan, Chen, Bingliang, Song, Guoda, Zeng, Kai, Li, Beining, Miao, Jianping, Liu, Chaofan, Luan, Yang, Liu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597358/
https://www.ncbi.nlm.nih.gov/pubmed/36313627
http://dx.doi.org/10.3389/fonc.2022.964838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597358/
https://www.ncbi.nlm.nih.gov/pubmed/36313627
http://dx.doi.org/10.3389/fonc.2022.964838

Ejemplares similares